Effectiveness of contemporary risk stratification in patients with hypertrophic cardiomyopathy: a pilot study

Back

ESC Professional Premium Access

Effectiveness of contemporary risk stratification in patients with hypertrophic cardiomyopathy: a pilot study

Session: Novel risk predictors in hypertrophic cardiomyopathy

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor M. Jensovsky (Prague, CZ)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Michael Jensovsky

Motol University Hospital, Prague (Czechia)

0 follower

5 more presentations in this session

Prediction of family inheritance in non-sarcomeric hypertrophic cardiomyopathy using clinical variables and 12-lead electrocardiogram artificial intelligence models

Speaker: Doctor M. Tremblay-Gravel (Montreal, CA)

Improving the prediction of major adverse cardiovascular events in patients with hypertrophic cardiomyopathy by adding plasma SVEP1 to conventional clinical model including NT-proBNP

Speaker: Doctor I. Osawa (New York, US)

Genotype predicts heart failure independent of left ventricular ejection fraction and NT-proBNP levels in hypertrophic cardiomyopathy

Speaker: Doctor A. Bakalakos (London, GB)

Impaired myocardial energetics in both sarcomere positive and negative HCM are linked to arrhythmic risk

Speaker: Doctor Z. Ashkir (Oxford, GB)

Myocardial scar in end-stage hypertrophic cardiomyopathy: correlation with systolic function and prognostic significance.

Speaker: Doctor R. Ditaranto (London, GB)

Access the full session

Novel risk predictors in hypertrophic cardiomyopathy

Speakers: Doctor M. Jensovsky, Doctor M. Tremblay-Gravel, Doctor I. Osawa, Doctor A. Bakalakos, Doctor Z. Ashkir...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources